CEL-SCI Corp. (CVM) Posts Wide Loss on Strong Revs
Get Alerts CVM Hot Sheet
Join SI Premium – FREE
CEL-SCI Corp. (NYSE: CVM) reported Q2 loss of ($0.07), $0.03 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $43.82 million versus the consensus estimate of $30 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CEL-SCI shares Phase 3 Multikine data showing 73% survival rate
- Hilton (HLT) Tops Q3 EPS by 10c, Misses on Revenue; Offers Guidance
- Nautilus Biotechnology, Inc. (NAUT) Tops Q3 EPS by 2c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share